Student awarded in more than 25 scientific Olympiads between 2013 and 2015, having participated in the International Biology Olympiad and Junior American Science Olympiad. Graduated in Pharmacy and Biochemistry at the University of São Paulo since 2017. Participated in the management of the student entity Social Academic Pharmacy in 2019 (Project Director) and 2020 (Vice President). He is currently undertaking scientific initiation with anti-chagasic planning using bioisosterism and molecular hybridization at the Faculty of Pharmaceutical Sciences. Also, he was a member of the iGEM-USP team in 2020 and 2021, having obtained together with this gold medal and being among the 10 best overgrad teams in the world. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| More itemsLess items |
| TITULO |
| Articles published in other media outlets ( ): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Considering that only nifurtimox and benznidazole are drugs available for Chagas disease, being less effective in the treatment of chronic phase of this disease, and, in addition, that this is a neglected disease, there is an urgent need for new and better chemotherapeutic agents, especially for chronic phase. Motivated by the urgency of finding new antichagasic agents, the objective of t…
Chagas disease (CD) is a prevalent anthropozoonosis in Latin America. Usually, this disease affects nearly 6-7 million people and kills around ten thousand annually. CD is caused by the parasite Trypanosoma cruzi, which is mainly transmitted by an insect vector popularly known as the kissing bug. Two drugs, benznidazole and nifurtimox, are currently approved for therapeutic use. Unfortuna…
| 1 / 1 | Completed scholarships in Brazil |
| 1 / 1 | Completed scholarships abroad |
| 2 / 2 | All Scholarships |
| Associated processes | |
CV Lattes
ORCID